The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target? - Wikidata - wikimedia - TriplyDB

The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?

The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?

http://www.wikidata.org/entity/Q38861278

about

Fecal metabolomics in pediatric spondyloarthritis implicate decreased metabolic diversity and altered tryptophan metabolism as pathogenic factors.Akkermansia muciniphila is permissive to arthritis in the K/BxN mouse model of arthritis.

P2860

Q36175670-12A15836-95C7-4D51-A324-C82480D0DF8F Q52723059-9AAE452B-00FA-4B3E-AF8A-582D3E3560E9

P2860

The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?

http://www.wikidata.org/entity/Q38861278

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?

@en

type

label

The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?

@en

prefLabel

The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?

@en

P1433

Q38861278-BDC852AC-64ED-4F71-B1D1-E782F930658E

P1476

Q38861278-EAB126DF-EE27-4CF0-B5F4-4AC3DA7EAED7

P2093

Q38861278-C63DE426-9461-40CF-8848-3C955B385126

P2860

Q38861278-07269251-416F-4B89-8CCB-FE167720FADD

Q38861278-096563F7-CE53-4845-BB5B-677EE9D7D68A

Q38861278-09B3A40C-DBBE-4A8E-9E28-0AE6C8EDAA49

Q38861278-0F2DA6B4-7B19-4F78-A836-CB9B846D1FA2

Q38861278-12FA77CB-250D-4186-A987-AF015FB1AAF4

Q38861278-1E0C1F6F-D98B-407C-92EF-F9E60470C433

Q38861278-1E28DAB4-FC20-4A56-9B31-AA2824C3C03F

Q38861278-21F7548A-2A67-4B2E-A715-6675BFEFB858

Q38861278-285DC4E8-1523-40CA-82A4-234AFA1F8EC1

Q38861278-297D28EC-15BE-4C74-A5C3-3E9265AF72E2

P304

Q38861278-0072E387-263E-420B-8855-E250130DC971

P31

Q38861278-6C173147-A037-4C81-8E3A-57C26B436B36

P356

Q38861278-B1EF3861-BDE3-47FE-98F7-9CD65BA3E981

P433

Q38861278-0CEBCA18-C5D3-4718-9CB5-B0392817F317

P478

Q38861278-CB7813C6-974D-4636-A5FA-602408C9B4DE

P50

Q38861278-B748B0F9-DB69-46C8-AB66-C77901999526

P577

Q38861278-A75177F7-2739-4641-BFB4-66C71CB2FD56

P698

Q38861278-416F0CE4-410B-41E4-87A4-2C39475A6057

P932

Q38861278-F1A51537-FEEA-455B-8AB6-5445E743BA18

P356

BOR.0000000000000312

P1433

Current Opinion in Rheumatology

P1476

The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?

@en

P2093

Matthew L Stoll

http://www.w3.org/2001/XMLSchema#string

P2860

Human gut microbiome viewed across age and geography

A human gut microbial gene catalogue established by metagenomic sequencing

A concise history of gout and hyperuricemia and their treatment

A core gut microbiome in obese and lean twins

HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats

An obesity-associated gut microbiome with increased capacity for energy harvest

Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

Succession of microbial consortia in the developing infant gut microbiome.

The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis

P304

537-543

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/BOR.0000000000000312

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Randy Quentin Cron

P577

2016-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27286235

http://www.w3.org/2001/XMLSchema#string

P932

4965316

http://www.w3.org/2001/XMLSchema#string